{
    "EVIDENCE": {
        "id": 4846,
        "name": "EID4846",
        "description": "Sequencing of 39 pediatric midline high-grade astrocytomas identified 5 patients with ACVR1 mutations. The authors identified an increase in endogenous phospho-SMAD1/5/8 signal in diffuse intrinsic pontine glioma (DIPG) cells harboring ACVR1 G328V, with corresponding increase in phospho-SMAD1/5/8 staining as well. By PCR, the authors show strong increase in fold change of mRNA expression in downstream proteins of the ACVR1/BMP pathway, ID, ID2, ID3 and SNAI1 in ACVR1-mutant DIPG cell line compared to glioblastoma cells (KNS42 cells). These activating ACVR1 mutations were exclusively in midline high grade astrocytomas (P = 0.0040, Fisher's exact test).",
        "disease": {
            "id": 2950,
            "name": "Diffuse Intrinsic Pontine Glioma",
            "display_name": "Diffuse Intrinsic Pontine Glioma",
            "doid": "0080684",
            "url": "http://www.disease-ontology.org/?id=DOID:0080684"
        },
        "drugs": [],
        "rating": 3,
        "evidence_level": "B",
        "evidence_type": "Diagnostic",
        "clinical_significance": "Positive",
        "evidence_direction": "Supports",
        "variant_origin": "Somatic",
        "drug_interaction_type": null,
        "status": "accepted",
        "type": "evidence",
        "source": {
            "id": 2149,
            "name": "Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.",
            "citation": "Fontebasso et al., 2014, Nat. Genet.",
            "citation_id": "24705250",
            "source_type": "PubMed",
            "asco_abstract_id": null,
            "source_url": "http://www.ncbi.nlm.nih.gov/pubmed/24705250",
            "open_access": true,
            "pmc_id": "PMC4282994",
            "publication_date": {
                "year": 2014,
                "month": 5
            },
            "journal": "Nat. Genet.",
            "full_journal_title": "Nature genetics",
            "status": "fully curated",
            "is_review": false,
            "clinical_trials": []
        },
        "variant_id": 1686,
        "phenotypes": [],
        "assertions": [
            {
                "id": 9,
                "type": "assertion",
                "name": "AID9",
                "summary": "Supports diagnosis of diffuse intrinsic pontine glioma.",
                "description": "ACVR1 G328V mutations occur within the kinase domain, leading to activation of downstream signaling. Exclusively seen in high-grade pediatric gliomas, supporting diagnosis of diffuse intrinsic pontine glioma.",
                "gene": {
                    "name": "ACVR1",
                    "id": 154
                },
                "variant": {
                    "name": "G328V",
                    "id": 1686
                },
                "disease": {
                    "id": 2950,
                    "name": "Diffuse Intrinsic Pontine Glioma",
                    "display_name": "Diffuse Intrinsic Pontine Glioma",
                    "doid": "0080684",
                    "url": "http://www.disease-ontology.org/?id=DOID:0080684"
                },
                "drugs": [],
                "evidence_type": "Diagnostic",
                "evidence_direction": "Supports",
                "clinical_significance": "Positive",
                "fda_regulatory_approval": false,
                "status": "accepted"
            }
        ],
        "gene_id": 154
    },
    "GENE": {
        "id": 154,
        "name": "ACVR1",
        "entrez_id": 90,
        "description": "",
        "variants": [
            {
                "name": "Gain-of-Function",
                "id": 2061,
                "evidence_items": {
                    "accepted_count": 1,
                    "rejected_count": 0,
                    "submitted_count": 0
                }
            },
            {
                "name": "R258G",
                "id": 2275,
                "evidence_items": {
                    "accepted_count": 0,
                    "rejected_count": 0,
                    "submitted_count": 1
                }
            },
            {
                "name": "G328V",
                "id": 1686,
                "evidence_items": {
                    "accepted_count": 2,
                    "rejected_count": 0,
                    "submitted_count": 2
                }
            },
            {
                "name": "MUTATION",
                "id": 2983,
                "evidence_items": {
                    "accepted_count": 0,
                    "rejected_count": 0,
                    "submitted_count": 1
                }
            },
            {
                "name": "G328W",
                "id": 2280,
                "evidence_items": {
                    "accepted_count": 0,
                    "rejected_count": 0,
                    "submitted_count": 1
                }
            },
            {
                "name": "G328E",
                "id": 2283,
                "evidence_items": {
                    "accepted_count": 1,
                    "rejected_count": 0,
                    "submitted_count": 0
                }
            }
        ],
        "aliases": [
            "ACVR1",
            "TSRI",
            "SKR1",
            "FOP",
            "ALK2",
            "ACVRLK2",
            "ACVR1A",
            "ACTRI"
        ],
        "type": "gene"
    },
    "VARIANT": {
        "id": 1686,
        "entrez_name": "ACVR1",
        "entrez_id": 90,
        "name": "G328V",
        "description": "",
        "gene_id": 154,
        "type": "variant",
        "variant_types": [
            {
                "id": 47,
                "name": "missense_variant",
                "display_name": "Missense Variant",
                "so_id": "SO:0001583",
                "description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",
                "url": "http://www.sequenceontology.org/browser/current_svn/term/SO:0001583"
            }
        ],
        "civic_actionability_score": 30,
        "coordinates": {
            "chromosome": "2",
            "start": 158622516,
            "stop": 158622516,
            "reference_bases": "C",
            "variant_bases": "A",
            "representative_transcript": "ENST00000434821.1",
            "chromosome2": null,
            "start2": null,
            "stop2": null,
            "representative_transcript2": null,
            "ensembl_version": 75,
            "reference_build": "GRCh37"
        },
        "evidence_items": [
            {
                "id": 8035,
                "name": "EID8035",
                "description": "Using mouse models, the authors demonstrated that Acvr1G328V arrested the differentiation of oligodendroglial lineage cells to generate high-grade diffuse gliomas. Using a cellular NanoBRET target engagement assay, they identified the binding between E6201 and ACVR1 with half maximal inhibitory concen- tration [IC50] \u2248 0.25 mM). Furthermore, in primary brainstem glial cells, they demonstrated that E6201 had a larger suppressive effect on BMP signaling pathway activation induced by mutant ACVR1 than by wild-type ACVR1. In addition, to obtain mechanistic insights into the inhibitory effect of E6201 on ACVR1, they solved the 1.5-A \u030a structure of ACVR1 in complex with its interacting partner E6201 by X-ray crystallography. And they showed that E6201 occupied the ATP-binding pocket of ACVR1 with a binding position similar to that in the equivalent MEK1 complex.",
                "disease": {
                    "id": 2950,
                    "name": "Diffuse Intrinsic Pontine Glioma",
                    "display_name": "Diffuse Intrinsic Pontine Glioma",
                    "doid": "0080684",
                    "url": "http://www.disease-ontology.org/?id=DOID:0080684"
                },
                "drugs": [
                    {
                        "id": 15211,
                        "name": "MEK-1/MEKK-1 Inhibitor E6201",
                        "ncit_id": "C79848",
                        "aliases": [
                            "E6201"
                        ]
                    }
                ],
                "rating": 3,
                "evidence_level": "D",
                "evidence_type": "Predictive",
                "clinical_significance": "Sensitivity/Response",
                "evidence_direction": "Supports",
                "variant_origin": "Somatic",
                "drug_interaction_type": null,
                "status": "submitted",
                "type": "evidence",
                "source": {
                    "id": 3226,
                    "name": "Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas.",
                    "citation": "Fortin et al., 2020, Cancer Cell",
                    "citation_id": "32142668",
                    "source_type": "PubMed",
                    "asco_abstract_id": null,
                    "source_url": "http://www.ncbi.nlm.nih.gov/pubmed/32142668",
                    "open_access": null,
                    "pmc_id": null,
                    "publication_date": {
                        "year": 2020,
                        "month": 2,
                        "day": 21
                    },
                    "journal": "Cancer Cell",
                    "full_journal_title": "Cancer cell",
                    "status": "submitted",
                    "is_review": false,
                    "clinical_trials": []
                },
                "variant_id": 1686,
                "phenotypes": []
            },
            {
                "id": 6092,
                "name": "EID6092",
                "description": "To investigate the specific role of ACVR1 mutations in the context of DIPG, a panel of four DIPG patient-derived primary cultures (and one thalamic paediatric GBM culture harbouring an H3F3A K27M mutation), representing two ACVR1 mutations (R206H and G328V) and three wild-type lines were assembled. RNAseq or Sanger data confirmed expression of mutant alleles. Treatment with the selective ALK2 inhibitor LDN-19318917 resulted in marked inhibition of cell viability in all cells, with GI50 values ranging from 0.86 \u2013 2.1 \u03bcM, approximately 10-fold lower than the less potent parent compound dorsomorphin, with a trend towards increased sensitivity in the mutant cultures (p=0.10, F-test)",
                "disease": {
                    "id": 2950,
                    "name": "Diffuse Intrinsic Pontine Glioma",
                    "display_name": "Diffuse Intrinsic Pontine Glioma",
                    "doid": "0080684",
                    "url": "http://www.disease-ontology.org/?id=DOID:0080684"
                },
                "drugs": [
                    {
                        "id": 604,
                        "name": "ALK2 Inhibitor LDN-193189",
                        "ncit_id": null,
                        "aliases": []
                    }
                ],
                "rating": 3,
                "evidence_level": "D",
                "evidence_type": "Predictive",
                "clinical_significance": "Sensitivity/Response",
                "evidence_direction": "Supports",
                "variant_origin": "Somatic",
                "drug_interaction_type": null,
                "status": "submitted",
                "type": "evidence",
                "source": {
                    "id": 2448,
                    "name": "Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.",
                    "citation": "Taylor et al., 2014, Nat. Genet.",
                    "citation_id": "24705252",
                    "source_type": "PubMed",
                    "asco_abstract_id": null,
                    "source_url": "http://www.ncbi.nlm.nih.gov/pubmed/24705252",
                    "open_access": true,
                    "pmc_id": "PMC4018681",
                    "publication_date": {
                        "year": 2014,
                        "month": 5
                    },
                    "journal": "Nat. Genet.",
                    "full_journal_title": "Nature genetics",
                    "status": "fully curated",
                    "is_review": false,
                    "clinical_trials": []
                },
                "variant_id": 1686,
                "phenotypes": []
            },
            {
                "id": 6955,
                "name": "EID6955",
                "description": "In a study sequencing 61 patients (median age 6.3) with diffuse intrinsic pontine glioma (DIPG), 12 variants affecting ACVR1 were observed. Five patients had G328V within the kinase domain. The ACVR1 G328V mutation was expressed using the pCDH511b vector in immortalized normal human astrocytes (iNHAs) where it activated downstream BMP signaling and enhanced cell growth. Activating ACVR1 mutations are recurrent and support diagnosis of high grade glioma. PEDIATRIC",
                "disease": {
                    "id": 2950,
                    "name": "Diffuse Intrinsic Pontine Glioma",
                    "display_name": "Diffuse Intrinsic Pontine Glioma",
                    "doid": "0080684",
                    "url": "http://www.disease-ontology.org/?id=DOID:0080684"
                },
                "drugs": [],
                "rating": 3,
                "evidence_level": "B",
                "evidence_type": "Diagnostic",
                "clinical_significance": "Positive",
                "evidence_direction": "Supports",
                "variant_origin": "Somatic",
                "drug_interaction_type": null,
                "status": "accepted",
                "type": "evidence",
                "source": {
                    "id": 2680,
                    "name": "Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.",
                    "citation": "Buczkowicz et al., 2014, Nat. Genet.",
                    "citation_id": "24705254",
                    "source_type": "PubMed",
                    "asco_abstract_id": null,
                    "source_url": "http://www.ncbi.nlm.nih.gov/pubmed/24705254",
                    "open_access": true,
                    "pmc_id": "PMC3997489",
                    "publication_date": {
                        "year": 2014,
                        "month": 5
                    },
                    "journal": "Nat. Genet.",
                    "full_journal_title": "Nature genetics",
                    "status": "partially curated",
                    "is_review": false,
                    "clinical_trials": []
                },
                "variant_id": 1686,
                "phenotypes": []
            },
            {
                "id": 4846,
                "name": "EID4846",
                "description": "Sequencing of 39 pediatric midline high-grade astrocytomas identified 5 patients with ACVR1 mutations. The authors identified an increase in endogenous phospho-SMAD1/5/8 signal in diffuse intrinsic pontine glioma (DIPG) cells harboring ACVR1 G328V, with corresponding increase in phospho-SMAD1/5/8 staining as well. By PCR, the authors show strong increase in fold change of mRNA expression in downstream proteins of the ACVR1/BMP pathway, ID, ID2, ID3 and SNAI1 in ACVR1-mutant DIPG cell line compared to glioblastoma cells (KNS42 cells). These activating ACVR1 mutations were exclusively in midline high grade astrocytomas (P = 0.0040, Fisher's exact test).",
                "disease": {
                    "id": 2950,
                    "name": "Diffuse Intrinsic Pontine Glioma",
                    "display_name": "Diffuse Intrinsic Pontine Glioma",
                    "doid": "0080684",
                    "url": "http://www.disease-ontology.org/?id=DOID:0080684"
                },
                "drugs": [],
                "rating": 3,
                "evidence_level": "B",
                "evidence_type": "Diagnostic",
                "clinical_significance": "Positive",
                "evidence_direction": "Supports",
                "variant_origin": "Somatic",
                "drug_interaction_type": null,
                "status": "accepted",
                "type": "evidence",
                "source": {
                    "id": 2149,
                    "name": "Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.",
                    "citation": "Fontebasso et al., 2014, Nat. Genet.",
                    "citation_id": "24705250",
                    "source_type": "PubMed",
                    "asco_abstract_id": null,
                    "source_url": "http://www.ncbi.nlm.nih.gov/pubmed/24705250",
                    "open_access": true,
                    "pmc_id": "PMC4282994",
                    "publication_date": {
                        "year": 2014,
                        "month": 5
                    },
                    "journal": "Nat. Genet.",
                    "full_journal_title": "Nature genetics",
                    "status": "fully curated",
                    "is_review": false,
                    "clinical_trials": []
                },
                "variant_id": 1686,
                "phenotypes": []
            }
        ],
        "variant_groups": [
            {
                "id": 23,
                "name": "ACVR1 kinase domain mutation",
                "description": "",
                "variants": [
                    {
                        "id": 1686,
                        "entrez_name": "ACVR1",
                        "entrez_id": 90,
                        "name": "G328V",
                        "description": "",
                        "gene_id": 154,
                        "type": "variant",
                        "variant_types": [
                            {
                                "id": 47,
                                "name": "missense_variant",
                                "display_name": "Missense Variant",
                                "so_id": "SO:0001583",
                                "description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",
                                "url": "http://www.sequenceontology.org/browser/current_svn/term/SO:0001583"
                            }
                        ],
                        "civic_actionability_score": 30,
                        "coordinates": {
                            "chromosome": "2",
                            "start": 158622516,
                            "stop": 158622516,
                            "reference_bases": "C",
                            "variant_bases": "A",
                            "representative_transcript": "ENST00000434821.1",
                            "chromosome2": null,
                            "start2": null,
                            "stop2": null,
                            "representative_transcript2": null,
                            "ensembl_version": 75,
                            "reference_build": "GRCh37"
                        }
                    },
                    {
                        "id": 2280,
                        "entrez_name": "ACVR1",
                        "entrez_id": 90,
                        "name": "G328W",
                        "description": "",
                        "gene_id": 154,
                        "type": "variant",
                        "variant_types": [
                            {
                                "id": 47,
                                "name": "missense_variant",
                                "display_name": "Missense Variant",
                                "so_id": "SO:0001583",
                                "description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",
                                "url": "http://www.sequenceontology.org/browser/current_svn/term/SO:0001583"
                            }
                        ],
                        "civic_actionability_score": 0,
                        "coordinates": {
                            "chromosome": "2",
                            "start": 158622517,
                            "stop": 158622517,
                            "reference_bases": "C",
                            "variant_bases": "A",
                            "representative_transcript": "ENST00000263640.3",
                            "chromosome2": null,
                            "start2": null,
                            "stop2": null,
                            "representative_transcript2": null,
                            "ensembl_version": 75,
                            "reference_build": "GRCh37"
                        }
                    },
                    {
                        "id": 2283,
                        "entrez_name": "ACVR1",
                        "entrez_id": 90,
                        "name": "G328E",
                        "description": "This mutation occurs within the kinase domain of ACVR1 and has been shown to be activating of downstream BMP signaling with increased cell proliferation in cells overexpressing this variant.",
                        "gene_id": 154,
                        "type": "variant",
                        "variant_types": [
                            {
                                "id": 47,
                                "name": "missense_variant",
                                "display_name": "Missense Variant",
                                "so_id": "SO:0001583",
                                "description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved.",
                                "url": "http://www.sequenceontology.org/browser/current_svn/term/SO:0001583"
                            },
                            {
                                "id": 160,
                                "name": "gain_of_function_variant",
                                "display_name": "Gain Of Function Variant",
                                "so_id": "SO:0002053",
                                "description": "A sequence variant whereby new or enhanced function is conferred on the gene product.",
                                "url": "http://www.sequenceontology.org/browser/current_svn/term/SO:0002053"
                            }
                        ],
                        "civic_actionability_score": 7.5,
                        "coordinates": {
                            "chromosome": null,
                            "start": null,
                            "stop": null,
                            "reference_bases": null,
                            "variant_bases": null,
                            "representative_transcript": null,
                            "chromosome2": null,
                            "start2": null,
                            "stop2": null,
                            "representative_transcript2": null,
                            "ensembl_version": null,
                            "reference_build": null
                        }
                    }
                ],
                "type": "variant_group"
            }
        ],
        "assertions": [
            {
                "id": 9,
                "type": "assertion",
                "name": "AID9",
                "summary": "Supports diagnosis of diffuse intrinsic pontine glioma.",
                "description": "ACVR1 G328V mutations occur within the kinase domain, leading to activation of downstream signaling. Exclusively seen in high-grade pediatric gliomas, supporting diagnosis of diffuse intrinsic pontine glioma.",
                "gene": {
                    "name": "ACVR1",
                    "id": 154
                },
                "variant": {
                    "name": "G328V",
                    "id": 1686
                },
                "disease": {
                    "id": 2950,
                    "name": "Diffuse Intrinsic Pontine Glioma",
                    "display_name": "Diffuse Intrinsic Pontine Glioma",
                    "doid": "0080684",
                    "url": "http://www.disease-ontology.org/?id=DOID:0080684"
                },
                "drugs": [],
                "evidence_type": "Diagnostic",
                "evidence_direction": "Supports",
                "clinical_significance": "Positive",
                "fda_regulatory_approval": false,
                "status": "accepted"
            }
        ],
        "variant_aliases": [
            "RS387906589",
            "GLY328VAL"
        ],
        "hgvs_expressions": [
            "ENST00000434821.1:c.983G>T",
            "NC_000002.11:g.158622516C>A",
            "NP_001096.1:p.Gly328Val",
            "NM_001105.4:c.983G>T"
        ],
        "clinvar_entries": [
            "376363"
        ],
        "allele_registry_id": "CA16602802"
    },
    "ASSERTIONS": [
        {
            "id": 9,
            "type": "assertion",
            "name": "AID9",
            "summary": "Supports diagnosis of diffuse intrinsic pontine glioma.",
            "description": "ACVR1 G328V mutations occur within the kinase domain, leading to activation of downstream signaling. Exclusively seen in high-grade pediatric gliomas, supporting diagnosis of diffuse intrinsic pontine glioma.",
            "gene": {
                "name": "ACVR1",
                "id": 154
            },
            "variant": {
                "name": "G328V",
                "id": 1686
            },
            "disease": {
                "id": 2950,
                "name": "Diffuse Intrinsic Pontine Glioma",
                "display_name": "Diffuse Intrinsic Pontine Glioma",
                "doid": "0080684",
                "url": "http://www.disease-ontology.org/?id=DOID:0080684"
            },
            "drugs": [],
            "evidence_type": "Diagnostic",
            "evidence_direction": "Supports",
            "clinical_significance": "Positive",
            "fda_regulatory_approval": false,
            "status": "accepted"
        }
    ]
}